UK cost watchdog says no to Novartis MS pill - Yahoo! News
Links shared publicly online about this topic.
- 94total visits
UK cost watchdog says no to Novartis MS pill - Yahoo! News
Read 'UK cost watchdog says no to Novartis MS pill' on Yahoo! News. LONDON (Reuters) - Novartis's multiple sclerosis pill Gilenya, one of its biggest new drug hopes, has been rejected by Britain's healthcare cost-effectiveness watchdog NICE, which judges it not worth using on the state health service.
View full resource at news.yahoo.com
Tags: Multiple Sclerosis, Drug, Healthcare, Healthy Living, Novartis, News
Most Recently Shared on August 5, 2011 at 8:49 pm By:
UK cost watchdog says no to Novartis MS pill: LONDON (Reuters) - Novartis's multiple sclerosis pill Gilenya, on... http://yhoo.it/nCekpL
Advertisement
